York Michael 4
4 · PhaseBio Pharmaceuticals Inc · Filed Nov 23, 2020
Insider Transaction Report
Form 4
York Michael
VP, Corporate Development
Transactions
- Award
Common Stock
2020-11-20$3.00/sh+2,662$7,986→ 4,162 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).